22nd May 2020

 Elasmogen, which is part of the Deepbridge Life Sciences EIS portfolio, are to collaborate with the University of Aberdeen as partner on a Scottish research award to assist with critical research to tackle the COVID-19 pandemic.

Caroline Barelle, CEO of Elasmogen commented;

“The Elasmogen team are delighted to be given the opportunity to deploy our soloMER technology platform..and are proud to be contributing to the global life sciences effort tackling this pandemic by working together with colleagues in Universities and other companies”.

To find out more about Elasmogen please click here.

Other News